top of page


Testing AI's Ability to Track Competitor Drug Pipelines
AI should excel at competitive intelligence tracking, so I decided to test how well current platforms perform on a real-world example: mapping the obesity drug development pipeline. My goal was to create a comprehensive table of all obesity drugs in Phase 2 and Phase 3 clinical trials in the US (excluding agents being developed exclusively in China or other Asian markets). Methodology First, I manually compiled a reference table using traditional research methods—reviewing Cl
Jan 28


Why Pharma's $10 Billion Ad Gamble May Be Coming to an End
Introduction One of the current administration's goals is to remove or at least restrict pharmaceutical direct-to-consumer (DTC)...
Sep 30, 2025


Efficacy improvements in First-line Renal Cell Carcinoma (RCC)
Success in oncology remains one of the most meaningful and competitive achievements in BioPharma. Over the past decade, checkpoint...
Sep 2, 2025


Why is Measles a killer?
When we think of measles, we typically think of an itchy rash but in fact measles is a respiratory infection with rash being one of the...
Mar 7, 2025


HPV Vaccine Efficacy
Figure 1 US rates of CIN2+ lesions by age group, adapted from Gargano et al 2019 The Human Papilloma Virus (HPV) vaccine...
Feb 24, 2025
bottom of page
